Skip to Content

Join the 'CMV Retinitis' group to help and get support from people like you.

CMV Retinitis News

Related terms: Cytomegalovirus (CMV) Retinitis, Cytomegalovirus Retinitis

FDA Medwatch Alert: Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter

Posted 18 Feb 2013 by

ISSUE: Gilead Sciences, Inc. is voluntarily recalling lot B120217A of Vistide® (cidofovir injection) to the user level due to the presence of  particulate matter found in some vials of this lot. Gilead is not currently aware of any complaint attributable to the particles. BACKGROUND: Vistide is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS).  Vistide is a sterile, hypertonic aqueous solution for intravenous infusion only.  The solution is clear, colorless and supplied in clear glass vials.  It is typically given in a hospital setting or in a doctor’s office. The lot number, B120217A,is located on the product label on the side of the vial. RECOMMENDATION: Gilead has notified its distributors and customers by e-mail and recall letter and is arranging for return of all recalled product. Before injecting Vistide, heal ... Read more

Related support groups: Cidofovir, Vistide, CMV Retinitis

Ask a Question

Further Information

Related Condition Support Groups

Cytomegalovirus (CMV) Infection

Related Drug Support Groups

Valcyte, ganciclovir, valganciclovir, foscarnet, cidofovir, Vitravene, Cytovene, Vistide, fomivirsen, Foscavir, Vitrasert